ActiTrexx GmbH
PrivateLast Round
Series A
Mar 2, 2021
Total Funding Raised
$8.65M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ActiTrexx GmbH is a biotechnology company developing cellular and biologic therapies based on activated regulatory T cells to address T cell-mediated autoimmune and autoinflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ActiTrexx GmbH Comparables
Compare ActiTrexx GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tr1X | 85% | |
| Cellenkos, Inc. | 83% | |
| Quell Therapeutics | 79% |
ActiTrexx GmbH Funding Rounds
Historical fundraising activity
ActiTrexx GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investitions- und Strukturbank Rheinland-Pfalz | Series A |
| Bundesministerium für Bildung und Forschung | Grant |
| MediVentures | Series A |
| LBBW Venture Capital GmbH | Series A |
| High-Tech Gründerfonds | Series A |
| LBBW Venture Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 262% MoM.
- Apr 16, 2026
Monthly visitors increased 35% MoM, from 66 to 89.
ActiTrexx GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ActiTrexx GmbH's valuation, stock price, and market status.
Is ActiTrexx GmbH a public or private company?
ActiTrexx GmbH is a private company.
What is the current stock price of ActiTrexx GmbH?
ActiTrexx GmbH is a private company, so its shares have no public market price. Caplight tracks ActiTrexx GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ActiTrexx GmbH worth (valuation)?
Valuation information for ActiTrexx GmbH is not publicly available.
Can I buy ActiTrexx GmbH stock?
ActiTrexx GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ActiTrexx GmbH's last funding round?
ActiTrexx GmbH's most recent funding round was Series A on March 2, 2021.
Who are the main investors in ActiTrexx GmbH?
Key investors in ActiTrexx GmbH include LBBW Venture Capital GmbH, LBBW Venture Capital.
Will ActiTrexx GmbH IPO soon?
No public IPO plans have been announced for ActiTrexx GmbH.
How can I track ActiTrexx GmbH secondary market activity?
Caplight tracks bids, offers, and trades in ActiTrexx GmbH's shares on secondary markets.